speb/financial-data huggingface dataset:
Financial ratios for PZC.L — quarterly report dated 2025-05-31
Capital expenditures: 0
Net tangible assets: -46216216.216216214
Buffett classification: The Gruesome
Stock price: 0.011216216216216216
Shares outstanding: 420353569
Book value: 288513513.51351357
P/B ratio: 0.016341614157845432
Market cap (USD): 4714776.517162162
Debt to equity: 0.8056206088992973
Current ratio: 1.0162297128589264
Quick ratio: 0.7249271743653767
Buyback yield (%): 0
Retained earnings: 540000000
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for QNST — annual report dated 2021-06-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 18.58
Shares outstanding: 57445370
Market cap (USD): 1067334974.5999999
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for QNST — annual report dated 2022-06-30
Total revenue: 582099000
Gross profit: 53731000
Operating income: -4718000
Net income: -5248000
Capital expenditures: 7514000
Operating cash flow: 28672000
Depreciation & amortization: 16961000
Net tangible assets: 115163000
Owner earnings: 4199000
Buffett classification: The Gruesome
Stock price: 10.06
Shares outstanding: 57445370
Book value: 286000000
P/B ratio: 2.020630846853147
Market cap (USD): 577900422.2
Debt to equity: 0.013489510489510489
Current ratio: 1.6681298423968096
Quick ratio: 1.6681298423968096
Interest coverage ratio: -4.388837209302325
COGS to revenue (%): 90.76943956268607
R&D to revenue (%): 3.763277380651745
SG&A to revenue (%): 6.277798106507657
Free cash flow (dilution-adjusted): 2652000
Buyback yield (%): 2.641977651076372
Retained earnings: -30214000
Receivables turnover: 7.137064737616479
Capitalized R&D asset: 21906000
ROCI (R&D-adjusted, %): 2.975595660915735
FCF margin (%): 0.4555926053815588
Rule of 40 score: 0.4555926053815588
Financial ratios for QNST — annual report dated 2023-06-30
Total revenue: 580624000
Gross profit: 48523000
Operating income: -20816000
Net income: -68866000
Capital expenditures: 15004000
Operating cash flow: 11838000
Depreciation & amortization: 19155000
Net tangible assets: 69960000
Owner earnings: -64715000
Return on net tangible assets (%): -92.50285877644369
Buffett classification: The Gruesome
Stock price: 8.83
Shares outstanding: 57445370
Book value: 229801000
P/B ratio: 2.207312488196309
Market cap (USD): 507242617.1
Debt to equity: 0.01992158432730928
Current ratio: 1.6834112669784012
Quick ratio: 1.6834112669784012
Interest coverage ratio: -26.349367088607593
COGS to revenue (%): 91.64295654330513
R&D to revenue (%): 4.976198021439004
SG&A to revenue (%): 6.965953870318829
Free cash flow (dilution-adjusted): -21952000
Buyback yield (%): 1.113076821557153
Retained earnings: -99080000
Receivables turnover: 8.555195379265633
Capitalized R&D asset: 43570020
ROCI (R&D-adjusted, %): -3.044292601069586
Rosenberg metric: -0.23774308408655162
FCF margin (%): -3.7807600099203613
Revenue growth (%): -0.2533933231288836
Rule of 40 score: -4.034153333049245
Financial ratios for QNST — annual report dated 2024-06-30
Total revenue: 613514000
Gross profit: 46246000
Operating income: -28065000
Net income: -31331000
Capital expenditures: 16725000
Operating cash flow: 12039000
Depreciation & amortization: 23957000
Net tangible assets: 53761000
Owner earnings: -24099000
Return on net tangible assets (%): -44.82617510834992
Buffett classification: The Gruesome
Stock price: 16.59
Shares outstanding: 57445370
Book value: 216825000
P/B ratio: 4.39533581598063
Market cap (USD): 953018688.3
Debt to equity: 0.05058918482647296
Current ratio: 1.3377347742844032
Quick ratio: 1.3377347742844032
Interest coverage ratio: -41.27205882352941
COGS to revenue (%): 92.46211170405239
R&D to revenue (%): 4.8971987599304985
SG&A to revenue (%): 7.215157274324628
Free cash flow (dilution-adjusted): -28387000
Buyback yield (%): 0.2400792374891774
Retained earnings: -130411000
Receivables turnover: 5.485198794803709
Capitalized R&D asset: 56632290
ROCI (R&D-adjusted, %): -8.356642267132147
Rosenberg metric: -0.07880801578236943
FCF margin (%): -4.626952278187621
Revenue growth (%): 5.664595331918763
Rule of 40 score: 1.0376430537311423
Financial ratios for QNST — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 19.13
Shares outstanding: 57445370
Market cap (USD): 1098929928.1
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for QNST — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 23.07
Shares outstanding: 57445370
Market cap (USD): 1325264685.9
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for QNST — quarterly report dated 2025-03-31
Total revenue: 269842000
Gross profit: 27862000
Operating income: 4912000
Net income: 4416000
Capital expenditures: 3013000
Operating cash flow: 30111000
Depreciation & amortization: 5969000
Net tangible assets: 79652000
Owner earnings: 7372000
Return on net tangible assets (%): 9.255260382664591
Capex to operating income (%): 61.33957654723127
Buffett classification: The Good
Stock price: 17.84
P/E ratio: 58.01774234601449
Shares outstanding: 57445370
Book value: 235475000
P/B ratio: 4.352162228686697
Market cap (USD): 1024825400.8
Debt to equity: 0.03393990869519057
Current ratio: 1.4577019799073234
Quick ratio: 1.4577019799073234
Effective tax rate (%): 9.748620478234212
Interest coverage ratio: 74.42424242424242
COGS to revenue (%): 89.67469852728634
R&D to revenue (%): 3.279697007878685
SG&A to revenue (%): 5.225279978654175
Free cash flow (dilution-adjusted): 20025000
Buyback yield (%): 0
Retained earnings: -128910000
Receivables turnover: 1.9661908613315262
Capitalized R&D asset: 8850000
ROCI (R&D-adjusted, %): 4.0131991641024305
FCF margin (%): 7.421009331386514
Rule of 40 score: 7.421009331386514
Financial ratios for QNST — quarterly report dated 2025-06-30
Total revenue: 262054000
Gross profit: 27850000
Operating income: 3876000
Net income: 3206000
Capital expenditures: 3055000
Operating cash flow: 29897000
Depreciation & amortization: 5858000
Net tangible assets: 90513000
Owner earnings: 6009000
Return on net tangible assets (%): 6.638825362102681
Capex to operating income (%): 78.81836945304438
Buffett classification: The Gruesome
Stock price: 16.1
P/E ratio: 121.34222736814486
Shares outstanding: 57445370
Book value: 244044000
P/B ratio: 3.789769291603154
Market cap (USD): 924870457.0000001
Debt to equity: 0.04177935126452607
Current ratio: 1.5058879811584602
Quick ratio: 1.5058879811584602
Effective tax rate (%): 14.483862363296879
Interest coverage ratio: 46.142857142857146
COGS to revenue (%): 89.372419425004
R&D to revenue (%): 2.935272882688301
SG&A to revenue (%): 6.213223228800171
Free cash flow (dilution-adjusted): 19608000
Buyback yield (%): 0
Retained earnings: -125704000
Receivables turnover: 1.929648611233837
Capitalized R&D asset: 13621500
ROCI (R&D-adjusted, %): 2.149213037991086
Rosenberg metric: -0.0013559322033898306
FCF margin (%): 7.4824272859792265
Revenue growth (%): -2.8861333669332425
Rule of 40 score: 4.5962939190459835
Financial ratios for QNST — annual report dated 2025-06-30
Total revenue: 1093711000
Gross profit: 110871000
Operating income: 6193000
Net income: 4707000
Capital expenditures: 11442000
Operating cash flow: 84980000
Depreciation & amortization: 24506000
Net tangible assets: 90513000
Owner earnings: 17771000
Return on net tangible assets (%): 19.633643785975497
Capex to operating income (%): 184.7569836912643
Buffett classification: The Gruesome
Stock price: 16.1
P/E ratio: 196.48830613979183
Shares outstanding: 57445370
Book value: 244044000
P/B ratio: 3.789769291603154
Market cap (USD): 924870457.0000001
Debt to equity: 0.04177935126452607
Current ratio: 1.5058879811584602
Quick ratio: 1.5058879811584602
Effective tax rate (%): 16.438842535061244
Interest coverage ratio: 15.4825
COGS to revenue (%): 89.8628613957435
R&D to revenue (%): 3.0969790008512303
SG&A to revenue (%): 6.473922270142661
Free cash flow (dilution-adjusted): 41772000
Buyback yield (%): 0
Retained earnings: -125704000
Receivables turnover: 8.053599304880564
Capitalized R&D asset: 63536840
ROCI (R&D-adjusted, %): 2.7528159643663677
Rosenberg metric: 2.1509402562822433
FCF margin (%): 3.819290470700212
Revenue growth (%): 78.2699335304492
Rule of 40 score: 82.0892240011494
Financial ratios for QNST — quarterly report dated 2025-09-30
Total revenue: 285853000
Gross profit: 26940000
Operating income: 4789000
Net income: 4535000
Capital expenditures: 4092000
Operating cash flow: 19601000
Depreciation & amortization: 5815000
Net tangible assets: 95461000
Owner earnings: 6258000
Return on net tangible assets (%): 6.555556719498015
Capex to operating income (%): 85.4458133221967
Buffett classification: The Gruesome
Stock price: 15.47
P/E ratio: 73.10026107592334
Shares outstanding: 57445370
Book value: 246699000
P/B ratio: 3.6022840542523484
Market cap (USD): 888679873.9000001
Debt to equity: 0.02835439138383212
Current ratio: 1.5081288299015478
Quick ratio: 1.5081288299015478
Effective tax rate (%): 3.8991311718584445
Interest coverage ratio: 70.42647058823529
COGS to revenue (%): 90.57557555806656
R&D to revenue (%): 2.854264254704341
SG&A to revenue (%): 4.894823563160085
Free cash flow (dilution-adjusted): 6306000
Buyback yield (%): 0.7589909705504359
Retained earnings: -121169000
Receivables turnover: 1.9059280842240016
Capitalized R&D asset: 16233140
ROCI (R&D-adjusted, %): 1.6442740559689355
Rosenberg metric: -0.11830473218928757
FCF margin (%): 2.2060289729336406
Revenue growth (%): 9.081715982202141
Rule of 40 score: 11.287744955135782
Financial ratios for QNST — quarterly report dated 2025-12-31
Total revenue: 287845000
Gross profit: 27722000
Operating income: 1247000
Net income: 50227000
Capital expenditures: 3470000
Operating cash flow: 21623000
Depreciation & amortization: 4934000
Net tangible assets: 144733000
Owner earnings: 51691000
Return on net tangible assets (%): 35.714729881920505
Capex to operating income (%): 278.2678428227747
Buffett classification: The Gruesome
Stock price: 14.37
P/E ratio: 13.232398802577585
Shares outstanding: 57445370
Book value: 294440000
P/B ratio: 2.8035931493682926
Market cap (USD): 825489966.9
Debt to equity: 0.02165806276321152
Current ratio: 1.5106260640156939
Quick ratio: 1.5106260640156939
Effective tax rate (%): -3734.12213740458
Interest coverage ratio: 17.814285714285713
COGS to revenue (%): 90.36912227066651
R&D to revenue (%): 2.889054873282496
SG&A to revenue (%): 6.308603588736994
Free cash flow (dilution-adjusted): 8601000
Buyback yield (%): 1.2177010506558588
Retained earnings: -70942000
Receivables turnover: 1.8888954510853873
Capitalized R&D asset: 16320890
ROCI (R&D-adjusted, %): 0.4540709220422181
Rosenberg metric: 0.09584507905380561
FCF margin (%): 2.9880664941200994
Revenue growth (%): 0.6968616736574393
Rule of 40 score: 3.6849281677775387
Financial ratios for REPL.NS — annual report dated 2022-03-31
Total revenue: 10112488.461031254
Gross profit: 6020269.02281419
Operating income: 2836581.8277726495
Net income: 1946314.123697745
Capital expenditures: 20123.961492812872
Operating cash flow: -1829407.886060926
Depreciation & amortization: 184320.1898984571
Net tangible assets: 11970143.742582092
Owner earnings: 2110510.3521033893
Return on net tangible assets (%): 17.631453702561213
Capex to operating income (%): 0.709444067355345
Buffett classification: The Great
Stock price: 2.8253989186337862
P/E ratio: 26.30782527830665
Shares outstanding: 18122500
Book value: 12228247.395489912
P/B ratio: 4.187296040626874
Market cap (USD): 51203291.90294079
Debt to equity: 0.12197983754426983
Current ratio: 2.854125472928705
Quick ratio: 2.854125472928705
Effective tax rate (%): 3.197400487408611
Interest coverage ratio: 41.5648309178744
COGS to revenue (%): 40.46698746788727
SG&A to revenue (%): 2.245869358267152
Free cash flow (dilution-adjusted): -1849531.8475537386
Buyback yield (%): 0
Retained earnings: 6685019.121719636
Receivables turnover: 1.226453117352961
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 22.719019830477144
FCF margin (%): -18.289581784750204
Rule of 40 score: -18.289581784750204
Financial ratios for REPL.NS — annual report dated 2023-03-31
Total revenue: 10623629.719853837
Gross profit: 5784202.192448234
Operating income: 2760596.833130329
Net income: 1464348.3556638246
Capital expenditures: 609987.8197320341
Operating cash flow: -419890.37758830696
Depreciation & amortization: 187381.24238733255
Net tangible assets: 12530511.571254568
Owner earnings: 1041741.778319123
Return on net tangible assets (%): 8.313641245972073
Capex to operating income (%): 22.096229786670783
Buffett classification: The Great
Stock price: 1.6443361753958587
P/E ratio: 20.34999542516823
Shares outstanding: 18122500
Book value: 12763349.57369062
P/B ratio: 2.3347697378780405
Market cap (USD): 29799482.33861145
Debt to equity: 0.10330756362185806
Current ratio: 2.5740935859747163
Quick ratio: 2.5740935859747163
Effective tax rate (%): 25.608722286506318
Interest coverage ratio: 16.32065960970692
COGS to revenue (%): 45.55342811281816
SG&A to revenue (%): 2.5114652602614083
Free cash flow (dilution-adjusted): -419890.37758830696
Buyback yield (%): 0
Retained earnings: 7638830.694275275
Receivables turnover: 1.0351649890632362
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 21.223210548444584
FCF margin (%): -3.952419169915157
Revenue growth (%): 5.054554680504993
Rule of 40 score: 1.1021355105898363
Financial ratios for REPL.NS — annual report dated 2024-03-31
Total revenue: 12056277.731142823
Gross profit: 6962873.246192589
Operating income: 3282120.158292361
Net income: 1685393.9321261542
Capital expenditures: 195203.26178198826
Operating cash flow: 32929.60786665068
Depreciation & amortization: 140940.1606907303
Net tangible assets: 14576675.860414919
Owner earnings: 1631130.8310348962
Return on net tangible assets (%): 11.190005503685988
Capex to operating income (%): 5.947474570326202
Buffett classification: The Great
Stock price: 2.0651391554702494
P/E ratio: 22.205778501763493
Shares outstanding: 18122500
Book value: 14830015.589399207
P/B ratio: 2.5236308161241636
Market cap (USD): 37425484.345009595
Debt to equity: 0.08212343582590415
Current ratio: 2.9180135650498626
Quick ratio: 2.9180135650498626
Effective tax rate (%): 25.866962072057813
Interest coverage ratio: 13.560719417331416
COGS to revenue (%): 42.246907366718624
SG&A to revenue (%): 1.5303772828591977
Free cash flow (dilution-adjusted): -228360.71471399447
Buyback yield (%): 0
Retained earnings: 9206067.873845784
Receivables turnover: 1.124432400270211
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 21.829057715851224
FCF margin (%): -1.8941228777777004
Revenue growth (%): 13.48548517849412
Rule of 40 score: 11.591362300716419
Financial ratios for REPL.NS — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: 15353213.09125657
Buffett classification: The Gruesome
Stock price: 2.5062111801242235
Shares outstanding: 18122500
Book value: 15561729.574773055
P/B ratio: 2.9186223737899395
Market cap (USD): 45418812.11180124
Debt to equity: 0.11713211567451727
Current ratio: 2.9131413284443486
Quick ratio: 2.9131413284443486
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for REPL.NS — quarterly report dated 2024-12-31
Total revenue: 3719244.66721063
Gross profit: 1793565.6836461124
Operating income: 852686.7933325561
Net income: 609604.8490500058
Capital expenditures: 0
Depreciation & amortization: 51917.47289893927
Owner earnings: 661522.321948945
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 3.5773400163189177
P/E ratio: 26.587036072125127
Shares outstanding: 18122500
Market cap (USD): 64830344.44573959
Effective tax rate (%): 26.07952055859447
Interest coverage ratio: 13.000177714590368
COGS to revenue (%): 51.776077022884984
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for REPL.NS — quarterly report dated 2025-03-31
Total revenue: 4288297.872340425
Gross profit: 1590425.5319148935
Operating income: 357645.5459434183
Net income: 201987.37432779986
Capital expenditures: 0
Depreciation & amortization: 19394.43535188216
Net tangible assets: 17362929.62356792
Owner earnings: 221381.80967968202
Return on net tangible assets (%): 1.2750256695113535
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 1.8535418368537755
P/E ratio: 41.57538565240831
Shares outstanding: 18122500
Book value: 17584860.88379705
P/B ratio: 1.910211980655111
Market cap (USD): 33590811.93838254
Debt to equity: 0.1086025944532974
Current ratio: 3.3347874869406193
Quick ratio: 3.3347874869406193
Effective tax rate (%): 37.8265563152213
Interest coverage ratio: 4.209273527793066
COGS to revenue (%): 62.91242867774747
Buyback yield (%): 0
Retained earnings: 10556476.502221182
Receivables turnover: 0.3267340049345767
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.0106338231814718
Revenue growth (%): 15.30023582870591
Rule of 40 score: 15.30023582870591
Financial ratios for REPL.NS — annual report dated 2025-03-31
Total revenue: 12621615.618424129
Gross profit: 6843009.118541033
Operating income: 2422001.4028524663
Net income: 1581821.3701192422
Capital expenditures: 541185.4103343465
Operating cash flow: -1448024.3161094224
Depreciation & amortization: 171358.42880523732
Net tangible assets: 17362929.62356792
Owner earnings: 1211994.3885901333
Return on net tangible assets (%): 6.980356511639652
Capex to operating income (%): 22.34455395843188
Buffett classification: The Great
Stock price: 1.8535418368537755
P/E ratio: 21.2355279634706
Shares outstanding: 18122500
Book value: 17584860.88379705
P/B ratio: 1.910211980655111
Market cap (USD): 33590811.93838254
Debt to equity: 0.1086025944532974
Current ratio: 3.3347874869406193
Quick ratio: 3.3347874869406193
Effective tax rate (%): 31.20802468821971
Interest coverage ratio: 8.869300911854102
COGS to revenue (%): 45.78341374497176
SG&A to revenue (%): 1.3810918878565612
Free cash flow (dilution-adjusted): -1994330.1379471591
Buyback yield (%): 0
Retained earnings: 10556476.502221182
Receivables turnover: 0.9616661767718604
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 13.616157101921711
FCF margin (%): -15.800910107228896
Revenue growth (%): 4.689157797194485
Rule of 40 score: -11.111752310034412
Financial ratios for REPL.NS — quarterly report dated 2025-06-30
Total revenue: 2309150.4797566114
Gross profit: 1253323.1921366723
Operating income: 424947.34378656687
Net income: 290802.714720337
Capital expenditures: 0
Depreciation & amortization: 37409.314299087295
Owner earnings: 328212.0290194243
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 2.091855838989001
P/E ratio: 34.38845383985535
Shares outstanding: 18122500
Market cap (USD): 37909657.44207817
Effective tax rate (%): 22.683010297732007
Interest coverage ratio: 4.7558931377684655
COGS to revenue (%): 45.72362420188508
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): -46.152283528374724
Rule of 40 score: -46.152283528374724
Financial ratios for REPL.NS — quarterly report dated 2025-09-30
Total revenue: 2434081.1724915444
Gross profit: 1334047.3506200677
Operating income: 218342.72829763245
Net income: 106651.63472378804
Capital expenditures: 0
Depreciation & amortization: 34081.17249154453
Net tangible assets: 17174329.19954904
Owner earnings: 140732.80721533258
Return on net tangible assets (%): 0.8194369956471307
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 1.6808342728297632
P/E ratio: 25.194165215870214
Shares outstanding: 18122500
Book value: 17390033.821871478
P/B ratio: 1.751630814601788
Market cap (USD): 30460919.109357383
Debt to equity: 0.15227268012364376
Current ratio: 2.7758312564956817
Quick ratio: 2.7758312564956817
Effective tax rate (%): 47.07988364287313
Interest coverage ratio: 2.4973565441650547
COGS to revenue (%): 45.19298018091458
Buyback yield (%): 0
Receivables turnover: 0.16892139826480465
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.2423623294854973
Revenue growth (%): 5.41024475581604
Rule of 40 score: 5.41024475581604
Financial ratios for REPL.NS — quarterly report dated 2025-12-31
Total revenue: 2351242.0630500168
Gross profit: 819371.7277486911
Operating income: 23638.18647655119
Net income: -153347.44346663696
Capital expenditures: 0
Depreciation & amortization: 35813.746240392116
Owner earnings: -117533.69722624484
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 1.3019939846273811
P/E ratio: 52.89327173229398
Shares outstanding: 18122500
Market cap (USD): 23595385.986409716
Interest coverage ratio: 0.20421518621884324
COGS to revenue (%): 65.15153668670732
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): -3.403301022896162
Rule of 40 score: -3.403301022896162
Financial ratios for RMTI — annual report dated 2021-12-31
Capital expenditures: 0
Depreciation & amortization: 2515000
Buffett classification: The Gruesome
Stock price: 45.1
Shares outstanding: 3947029
Market cap (USD): 178011007.9
Buyback yield (%): 0.003370578073110275
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for RMTI — annual report dated 2022-12-31
Total revenue: 72810000
Gross profit: 4077000
Operating income: -16780000
Net income: -18679000
Capital expenditures: 281000
Operating cash flow: -16929000
Depreciation & amortization: 2589000
Net tangible assets: 13185000
Owner earnings: -16371000
Return on net tangible assets (%): -124.16382252559728
Buffett classification: The Gruesome
Stock price: 10.1
Shares outstanding: 3947029
Book value: 14106000
P/B ratio: 2.826101864454842
Market cap (USD): 39864992.9
Debt to equity: 1.1600028356727634
Current ratio: 1.9959301339664237
Quick ratio: 1.6672884517551296
Interest coverage ratio: -8.667355371900827
COGS to revenue (%): 94.40049443757725
R&D to revenue (%): 4.283752231836286
SG&A to revenue (%): 24.362038181568465
Free cash flow (dilution-adjusted): -17525000
Buyback yield (%): 0
Retained earnings: -388759000
Inventory turnover: 11.821981424148607
Receivables turnover: 11.63284869787506
Capitalized R&D asset: 3119000
ROCI (R&D-adjusted, %): -45.84931748952582
FCF margin (%): -24.06949594835874
Rule of 40 score: -24.06949594835874
Financial ratios for RMTI — annual report dated 2023-12-31
Total revenue: 83612000
Gross profit: 8704000
Operating income: -6670000
Net income: -8439000
Capital expenditures: 284000
Operating cash flow: -9412000
Depreciation & amortization: 1444000
Net tangible assets: 9611000
Owner earnings: -7279000
Return on net tangible assets (%): -75.73613567786911
Buffett classification: The Gruesome
Stock price: 18.9
Shares outstanding: 3947029
Book value: 21291000
P/B ratio: 3.5037738058334504
Market cap (USD): 74598848.1
Debt to equity: 0.6312056737588653
Current ratio: 1.7292781150447798
Quick ratio: 1.376389974153994
Interest coverage ratio: -2.898739678400695
COGS to revenue (%): 89.59001100320528
R&D to revenue (%): 1.323972635506865
SG&A to revenue (%): 17.06334019040329
Free cash flow (dilution-adjusted): -10628000
Buyback yield (%): 0
Retained earnings: -397198000
Inventory turnover: 12.758984840742633
Receivables turnover: 7.670122007155307
Capitalized R&D asset: 3196730
ROCI (R&D-adjusted, %): -17.99941978442177
Rosenberg metric: 1.48348829753126
FCF margin (%): -12.711094101325168
Revenue growth (%): 14.835874193105342
Rule of 40 score: 2.124780091780174
Financial ratios for RMTI — quarterly report dated 2024-09-30
Capital expenditures: 0
Depreciation & amortization: 400000
Buffett classification: The Gruesome
Stock price: 39.7
Shares outstanding: 3947029
Market cap (USD): 156697051.3
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for RMTI — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 20.4
Shares outstanding: 3947029
Market cap (USD): 80519391.6
Buyback yield (%): 0
Capitalized R&D asset: 1000
Rule of 40 score: 0
Financial ratios for RMTI — annual report dated 2024-12-31
Total revenue: 101489000
Gross profit: 17484000
Operating income: 608000
Net income: -480000
Capital expenditures: 1011000
Operating cash flow: 4202000
Depreciation & amortization: 2180000
Net tangible assets: 21458000
Owner earnings: 689000
Capex to operating income (%): 166.2828947368421
Buffett classification: The Gruesome
Stock price: 20.4
Shares outstanding: 3947029
Book value: 32586000
P/B ratio: 2.4709811452771127
Market cap (USD): 80519391.6
Debt to equity: 0.4153624255815381
Current ratio: 2.6279185295578738
Quick ratio: 2.2178695621318574
Interest coverage ratio: 0.48484848484848486
COGS to revenue (%): 82.77251721861482
R&D to revenue (%): 0.01872124072559588
SG&A to revenue (%): 16.609681837440508
Free cash flow (dilution-adjusted): 1899000
Buyback yield (%): 0
Retained earnings: -397678000
Inventory turnover: 14.538767739702319
Receivables turnover: 12.240863587022073
Capitalized R&D asset: 1789960
ROCI (R&D-adjusted, %): -1.679921273943142
Rosenberg metric: 7.931345980126468
FCF margin (%): 1.871138744100346
Revenue growth (%): 21.380902262833086
Rule of 40 score: 23.252041006933432
Financial ratios for RMTI — quarterly report dated 2025-03-31
Total revenue: 18914000
Gross profit: 3042000
Operating income: -1360000
Net income: -1515000
Capital expenditures: 63000
Operating cash flow: -3487000
Depreciation & amortization: 539000
Net tangible assets: 20532000
Owner earnings: -1039000
Return on net tangible assets (%): -5.060393532047536
Buffett classification: The Gruesome
Stock price: 11.3
Shares outstanding: 3947029
Book value: 31522000
P/B ratio: 1.4149301345092318
Market cap (USD): 44601427.7
Debt to equity: 0.40822282850072966
Current ratio: 2.948148148148148
Quick ratio: 2.4979027219991075
Interest coverage ratio: -4.909747292418772
COGS to revenue (%): 83.91667547848155
R&D to revenue (%): 0
SG&A to revenue (%): 23.273765464735117
Free cash flow (dilution-adjusted): -3995000
Buyback yield (%): 0
Retained earnings: -399193000
Inventory turnover: 3.1460852329038653
Receivables turnover: 1.9559462254395037
Capitalized R&D asset: 670
ROCI (R&D-adjusted, %): -3.1815698774795447
FCF margin (%): -21.121920270698954
Rule of 40 score: -21.121920270698954
Financial ratios for RMTI — quarterly report dated 2025-06-30
Total revenue: 16071000
Gross profit: 2503000
Operating income: -1349000
Net income: -1492000
Capital expenditures: 164000
Operating cash flow: 1844000
Depreciation & amortization: 563000
Net tangible assets: 19557000
Owner earnings: -1093000
Return on net tangible assets (%): -5.588791736973973
Buffett classification: The Gruesome
Stock price: 8.5
Shares outstanding: 3947029
Book value: 30409000
P/B ratio: 1.1032834522674209
Market cap (USD): 33549746.5
Debt to equity: 0.46062021112170737
Current ratio: 2.8877215421158415
Quick ratio: 2.5076740361775993
Interest coverage ratio: -4.88768115942029
COGS to revenue (%): 84.42536245410989
R&D to revenue (%): 0
SG&A to revenue (%): 23.968639163711032
Free cash flow (dilution-adjusted): 1298000
Buyback yield (%): 0
Retained earnings: -400685000
Inventory turnover: 3.2615384615384615
Receivables turnover: 1.9880009896091044
Capitalized R&D asset: 330
ROCI (R&D-adjusted, %): -3.237416084503598
FCF margin (%): 8.076659822039698
Revenue growth (%): -15.03119382468013
Rule of 40 score: -6.9545340026404325
Financial ratios for RMTI — quarterly report dated 2025-09-30
Total revenue: 15927000
Gross profit: 2272000
Operating income: -1584000
Net income: -1753000
Capital expenditures: 229000
Operating cash flow: -1307000
Depreciation & amortization: 544000
Net tangible assets: 26305000
Owner earnings: -1438000
Return on net tangible assets (%): -5.466641322942407
Buffett classification: The Gruesome
Stock price: 12
Shares outstanding: 3947029
Book value: 37020000
P/B ratio: 1.2794259319286871
Market cap (USD): 47364348
Debt to equity: 0.35453808752025934
Current ratio: 3.9150490503026507
Quick ratio: 3.501356710498852
Interest coverage ratio: -5.557894736842106
COGS to revenue (%): 85.73491555220694
R&D to revenue (%): 0
SG&A to revenue (%): 24.210460224775538
Free cash flow (dilution-adjusted): -2068000
Buyback yield (%): 0
Retained earnings: -402438000
Inventory turnover: 3.444752774974773
Receivables turnover: 1.912463976945245
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -3.306613226452906
FCF margin (%): -12.984240597727132
Revenue growth (%): -0.8960238939705059
Rule of 40 score: -13.880264491697638
Financial ratios for RMTI — quarterly report dated 2025-12-31
Total revenue: 18346000
Gross profit: 3878000
Operating income: -398000
Net income: -554000
Capital expenditures: 86000
Operating cash flow: 2291000
Depreciation & amortization: 546000
Net tangible assets: 26404000
Owner earnings: -94000
Return on net tangible assets (%): -0.3560066656567187
Buffett classification: The Gruesome
Stock price: 8.3
Shares outstanding: 3947029
Book value: 36981000
P/B ratio: 0.8858695194829779
Market cap (USD): 32760340.700000003
Debt to equity: 0.3372542657040102
Current ratio: 3.9836116910229644
Quick ratio: 3.6262004175365345
Interest coverage ratio: -1.3916083916083917
COGS to revenue (%): 78.86187724844653
R&D to revenue (%): 0
SG&A to revenue (%): 23.307532977215743
Free cash flow (dilution-adjusted): 1748000
Buyback yield (%): 0
Retained earnings: -402992000
Inventory turnover: 4.225467289719626
Receivables turnover: 2.25297801792951
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.8367497109218963
FCF margin (%): 9.527962498637304
Revenue growth (%): 15.188045457399385
Rule of 40 score: 24.71600795603669
Financial ratios for RMTI — annual report dated 2025-12-31
Total revenue: 69258000
Gross profit: 11695000
Operating income: -4691000
Net income: -5314000
Capital expenditures: 542000
Operating cash flow: -659000
Depreciation & amortization: 2192000
Net tangible assets: 26404000
Owner earnings: -3664000
Return on net tangible assets (%): -13.876685350704438
Buffett classification: The Gruesome
Stock price: 8.3
Shares outstanding: 3947029
Book value: 36981000
P/B ratio: 0.8858695194829779
Market cap (USD): 32760340.700000003
Debt to equity: 0.3372542657040102
Current ratio: 3.9836116910229644
Quick ratio: 3.6262004175365345
Interest coverage ratio: -4.173487544483986
COGS to revenue (%): 83.11386410234198
R&D to revenue (%): 0
SG&A to revenue (%): 23.659360651477083
Free cash flow (dilution-adjusted): -3017000
Buyback yield (%): 0
Retained earnings: -402992000
Inventory turnover: 16.8116238317757
Receivables turnover: 8.505219206680584
Capitalized R&D asset: 378040
ROCI (R&D-adjusted, %): -10.567401093742351
Rosenberg metric: -304.6842105263158
FCF margin (%): -4.356175459874671
Revenue growth (%): -31.758121569825303
Rule of 40 score: -36.114297029699976
Financial ratios for SAGCEM.NS — annual report dated 2022-03-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 3.2166688645654755
Shares outstanding: 130707548
Market cap (USD): 420442900.0152974
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for SAGCEM.NS — annual report dated 2023-03-31
Total revenue: 270757612.6674787
Gross profit: 204203410.47503045
Operating income: 198538.36784409257
Net income: 3672350.791717418
Capital expenditures: 161997.56394640682
Operating cash flow: 21334957.369062122
Depreciation & amortization: 18973203.41047503
Net tangible assets: 227032886.72350794
Owner earnings: 22483556.63824604
Return on net tangible assets (%): 9.90321576874792
Capex to operating income (%): 81.59509202453987
Buffett classification: The Gruesome
Stock price: 2.297563946406821
P/E ratio: 81.7756709095854
Shares outstanding: 130707548
Book value: 251496954.93300852
P/B ratio: 1.1940858285462446
Market cap (USD): 300308949.808039
Debt to equity: 0.7160534485347179
Current ratio: 0.9776304120504573
Quick ratio: 0.6190022369587949
Effective tax rate (%): 47.96968056307526
Interest coverage ratio: 0.011021705321522754
COGS to revenue (%): 24.580731650261818
SG&A to revenue (%): 20.24814208338582
Free cash flow (dilution-adjusted): 6993909.866017053
Buyback yield (%): 0
Retained earnings: 82114494.51887941
Inventory turnover: 2.0167195689082456
Receivables turnover: 16.68733578560168
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.04759499288995045
FCF margin (%): 2.583088910082234
Rule of 40 score: 2.583088910082234
Financial ratios for SAGCEM.NS — annual report dated 2024-03-31
Total revenue: 299586281.3286965
Gross profit: 234655234.4405804
Operating income: 3911740.0167885837
Net income: -5199664.228324739
Capital expenditures: 3083103.4896270535
Operating cash flow: 48015349.562297635
Depreciation & amortization: 25675740.496462405
Net tangible assets: 217524883.07950592
Owner earnings: 17392972.77851061
Capex to operating income (%): 78.81667688534641
Buffett classification: The Gruesome
Stock price: 2.491962571976967
Shares outstanding: 130707548
Book value: 242198105.28840393
P/B ratio: 1.3448425498747192
Market cap (USD): 325718317.4908829
Debt to equity: 0.7150008169570576
Current ratio: 0.8598843008178736
Quick ratio: 0.5531418312387792
Interest coverage ratio: 0.20598636019196767
COGS to revenue (%): 21.673571500050034
SG&A to revenue (%): 21.583108175723005
Free cash flow (dilution-adjusted): 20938961.5061758
Buyback yield (%): 0
Retained earnings: 74547307.83067514
Inventory turnover: 1.7606165051700593
Receivables turnover: 12.027007510109764
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.9726831682873083
FCF margin (%): 6.989292504753328
Revenue growth (%): 10.647408350664811
Rule of 40 score: 17.63670085541814
Financial ratios for SAGCEM.NS — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: 215660535.11705685
Buffett classification: The Gruesome
Stock price: 2.7556139512661253
Shares outstanding: 130707548
Book value: 229446966.07740086
P/B ratio: 1.569772522871734
Market cap (USD): 360179542.8045867
Debt to equity: 0.7743332656577803
Current ratio: 0.6953703787871902
Quick ratio: 0.42543791871574144
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for SAGCEM.NS — quarterly report dated 2024-12-31
Total revenue: 65727940.31938454
Gross profit: 53830283.24979601
Operating income: -2444340.8322648327
Net income: -6346893.577340016
Capital expenditures: 0
Depreciation & amortization: 6831798.577922834
Owner earnings: 484905.00058281794
Buffett classification: The Gruesome
Stock price: 2.598904301200606
Shares outstanding: 130707548
Market cap (USD): 339696408.69658464
Interest coverage ratio: -0.4362388183898481
COGS to revenue (%): 18.101369085621055
SG&A to revenue (%): 20.387316450308575
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for SAGCEM.NS — annual report dated 2025-03-31
Total revenue: 256905541.2672434
Gross profit: 190662847.79050735
Operating income: -10195230.301613279
Net income: -24525368.248772502
Capital expenditures: 960953.9396773438
Operating cash flow: 27347439.7942483
Depreciation & amortization: 26975683.890577506
Net tangible assets: 186980360.06546643
Owner earnings: 1489361.7021276606
Buffett classification: The Gruesome
Stock price: 2.098961372388844
Shares outstanding: 130707548
Book value: 209765022.21183074
P/B ratio: 1.3078924762518742
Market cap (USD): 274350094.3316607
Debt to equity: 0.8057603673794674
Current ratio: 0.5807584211096933
Quick ratio: 0.35258158406098056
Interest coverage ratio: -0.551927093221948
COGS to revenue (%): 25.78484416878643
SG&A to revenue (%): 23.411313405261264
Free cash flow (dilution-adjusted): 11197100.771568855
Buyback yield (%): 0
Retained earnings: 47078559.738134205
Inventory turnover: 2.0710526315789473
Receivables turnover: 10.763432433756183
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -2.928937743700315
FCF margin (%): 4.358450470292186
Revenue growth (%): -14.246560247071246
Rule of 40 score: -9.88810977677906
Financial ratios for SAGCEM.NS — quarterly report dated 2025-03-31
Total revenue: 76927753.09796585
Gross profit: 62636193.593640395
Operating income: -2518120.1776946457
Net income: -8273322.422258592
Capital expenditures: 0
Depreciation & amortization: 6822539.162964694
Net tangible assets: 186980360.06546643
Owner earnings: -1450783.259293898
Return on net tangible assets (%): -0.775901414879051
Buffett classification: The Gruesome
Stock price: 2.098961372388844
Shares outstanding: 130707548
Book value: 209765022.21183074
P/B ratio: 1.3078924762518742
Market cap (USD): 274350094.3316607
Debt to equity: 0.8057603673794674
Current ratio: 0.5807584211096933
Quick ratio: 0.35258158406098056
Interest coverage ratio: -0.4552948636651871
COGS to revenue (%): 18.577898000121575
SG&A to revenue (%): 21.097501671630905
Buyback yield (%): 0
Retained earnings: 47078559.738134205
Inventory turnover: 0.4468201754385965
Receivables turnover: 3.223000440809129
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.7234184038447975
Revenue growth (%): 17.039652732398576
Rule of 40 score: 17.039652732398576
Financial ratios for SAGCEM.NS — quarterly report dated 2025-06-30
Total revenue: 78476480.22466652
Gross profit: 68666042.59302598
Operating income: 7816522.349637258
Net income: 876433.419143459
Capital expenditures: 0
Depreciation & amortization: 6394804.58694126
Owner earnings: 7271238.006084719
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 2.7993213199157503
P/E ratio: 104.36971531388518
Shares outstanding: 130707548
Market cap (USD): 365892425.7903113
Effective tax rate (%): 68.6610878661088
Interest coverage ratio: 1.4185602038649394
COGS to revenue (%): 12.501118301374763
SG&A to revenue (%): 19.309337070945038
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): 2.013222880341245
Rule of 40 score: 2.013222880341245
Financial ratios for SAGCEM.NS — quarterly report dated 2025-12-31
Total revenue: 65783669.37729754
Gross profit: 56085551.96613568
Operating income: -2826111.172997661
Net income: -6414169.544391222
Capital expenditures: 0
Depreciation & amortization: 7022390.553637072
Owner earnings: 608221.0092458501
Buffett classification: The Gruesome
Stock price: 2.388659908655453
Shares outstanding: 130707548
Market cap (USD): 312215879.6662583
Interest coverage ratio: -0.5044740505070591
COGS to revenue (%): 14.742439123514073
SG&A to revenue (%): 20.936769736173673
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): -16.174031774910578
Rule of 40 score: -16.174031774910578
Financial ratios for SCOT.V — annual report dated 2021-08-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.9047619047619047
Shares outstanding: 76620342
Market cap (USD): 69323166.57142857
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for SCOT.V — annual report dated 2022-08-31
Total revenue: 0
Operating income: -8109649.61832061
Net income: -7263962.595419847
Capital expenditures: 46180.91603053435
Operating cash flow: -4929706.870229008
Depreciation & amortization: 57951.908396946565
Net tangible assets: 12191859.541984733
Owner earnings: -7252191.603053436
Return on net tangible assets (%): -59.483884128416065
Buffett classification: The Gruesome
Stock price: 0.7557251908396946
Shares outstanding: 76620342
Book value: 12191859.541984731
P/B ratio: 4.749392197371591
Market cap (USD): 57903922.58015267
Debt to equity: 0
Current ratio: 1.4004916133656833
Quick ratio: 1.4004916133656833
Free cash flow (dilution-adjusted): -6394008.396946564
Buyback yield (%): 0
Retained earnings: -19700529.007633585
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -65.27981092794171
Rule of 40 score: 0
Financial ratios for SCOT.V — annual report dated 2023-08-31
Total revenue: 0
Operating income: -8394993.333333332
Net income: -14128923.703703703
Capital expenditures: 77743.7037037037
Operating cash flow: -8147468.148148147
Depreciation & amortization: 55023.7037037037
Net tangible assets: 5134257.037037036
Owner earnings: -14151643.703703703
Return on net tangible assets (%): -275.63177304170523
Buffett classification: The Gruesome
Stock price: 1.0666666666666667
Shares outstanding: 76620342
Book value: 5134257.037037036
P/B ratio: 15.918245660557186
Market cap (USD): 81728364.8
Debt to equity: 0
Current ratio: 1.0395797772807303
Quick ratio: 1.0395797772807303
Free cash flow (dilution-adjusted): -9256748.148148147
Buyback yield (%): 0
Retained earnings: -33245733.333333332
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -163.50940891299933
Rule of 40 score: 0
Financial ratios for SCOT.V — annual report dated 2024-08-31
Total revenue: 0
Operating income: -5615978.518518518
Net income: -2881740.7407407407
Capital expenditures: 5992148.148148147
Operating cash flow: -5393330.37037037
Depreciation & amortization: 55291.11111111111
Net tangible assets: 7299540.740740741
Owner earnings: -8818597.777777776
Return on net tangible assets (%): -120.8103097302925
Buffett classification: The Gruesome
Stock price: 0.8
Shares outstanding: 76620342
Book value: 7299540.74074074
P/B ratio: 8.397278099687654
Market cap (USD): 61296273.6
Debt to equity: 0
Current ratio: 5.565140105642546
Quick ratio: 5.565140105642546
Free cash flow (dilution-adjusted): -5990060.740740741
Buyback yield (%): 0
Retained earnings: -36127474.074074075
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -76.93605280088651
Rule of 40 score: 0
Financial ratios for SCOT.V — quarterly report dated 2024-11-30
Capital expenditures: 1400
Depreciation & amortization: 11161.428571428572
Buffett classification: The Gruesome
Stock price: 0.6857142857142857
Shares outstanding: 76620342
Market cap (USD): 52539663.08571429
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for SCOT.V — quarterly report dated 2025-02-28
Total revenue: 0
Gross profit: 0
Operating income: -814440.2777777778
Net income: -728904.1666666667
Capital expenditures: 0
Operating cash flow: 170103.47222222222
Depreciation & amortization: 10644.444444444445
Net tangible assets: 5039737.5
Owner earnings: -718259.7222222222
Return on net tangible assets (%): -14.251927252604371
Buffett classification: The Gruesome
Stock price: 0.625
Shares outstanding: 76620342
Book value: 5039737.5
P/B ratio: 9.502025403108792
Market cap (USD): 47887713.75
Debt to equity: 0
Current ratio: 24.36181626980041
Quick ratio: 24.36181626980041
Free cash flow (dilution-adjusted): 101130.55555555555
Buyback yield (%): 0
Retained earnings: -35931698.61111111
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -16.1603710069776
Rule of 40 score: 0
Financial ratios for SCOT.V — quarterly report dated 2025-05-31
Total revenue: 0
Operating income: -749182.6086956522
Net income: -723975.3623188407
Capital expenditures: 122449.27536231885
Operating cash flow: -538252.8985507247
Depreciation & amortization: 15272.463768115944
Net tangible assets: 4663399.275362319
Owner earnings: -831152.1739130436
Return on net tangible assets (%): -17.822882511994813
Buffett classification: The Gruesome
Stock price: 0.6666666666666667
Shares outstanding: 76620342
Book value: 4663399.275362319
P/B ratio: 10.95343224627305
Market cap (USD): 51080228.00000001
Debt to equity: 0
Current ratio: 24.494152622029862
Quick ratio: 24.494152622029862
Free cash flow (dilution-adjusted): -789220.2898550725
Buyback yield (%): 0
Retained earnings: -38217921.73913044
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -16.065161150874115
Rule of 40 score: 0
Financial ratios for SCOT.V — quarterly report dated 2025-08-31
Total revenue: 0
Operating income: -5604844.525547445
Net income: -5087906.569343065
Capital expenditures: 21762.773722627735
Operating cash flow: -2799205.8394160583
Depreciation & amortization: 19532.116788321167
Net tangible assets: 7427313.868613138
Owner earnings: -5090137.226277372
Return on net tangible assets (%): -68.53267973213882
Buffett classification: The Gruesome
Stock price: 0.8832116788321167
Shares outstanding: 76620342
Book value: 7427313.868613138
P/B ratio: 9.111232147665648
Market cap (USD): 67671980.89051095
Debt to equity: 0
Current ratio: 3.0012843467542503
Quick ratio: 3.0012843467542503
Free cash flow (dilution-adjusted): -3042986.131386861
Buyback yield (%): 0
Retained earnings: -43584791.24087591
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -75.46260498338152
Rule of 40 score: 0
Financial ratios for SCOT.V — annual report dated 2025-08-31
Total revenue: 0
Operating income: -8665801.459854014
Net income: -7984725.547445254
Capital expenditures: 146536.49635036496
Operating cash flow: -5447096.3503649635
Depreciation & amortization: 57510.21897810219
Net tangible assets: 7427313.868613138
Owner earnings: -8073751.824817517
Return on net tangible assets (%): -108.70352280298994
Buffett classification: The Gruesome
Stock price: 0.8832116788321167
Shares outstanding: 76620342
Book value: 7427313.868613138
P/B ratio: 9.111232147665648
Market cap (USD): 67671980.89051095
Debt to equity: 0
Current ratio: 3.0012843467542503
Quick ratio: 3.0012843467542503
Free cash flow (dilution-adjusted): -6216929.927007299
Buyback yield (%): 0
Retained earnings: -43584791.24087591
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -116.67477116423697
Rule of 40 score: 0
Financial ratios for SCOT.V — quarterly report dated 2025-11-30
Total revenue: 0
Operating income: -5652734.285714286
Net income: -5312910.714285715
Capital expenditures: 0
Operating cash flow: -7065870
Depreciation & amortization: 20027.857142857145
Net tangible assets: 6997067.142857144
Owner earnings: -5292882.857142857
Return on net tangible assets (%): -75.64430566521033
Buffett classification: The Gruesome
Stock price: 1.1500000000000001
Shares outstanding: 76620342
Book value: 6997067.142857143
P/B ratio: 12.592903783973163
Market cap (USD): 88113393.30000001
Debt to equity: 0
Current ratio: 5.099107470006294
Quick ratio: 5.099107470006294
Free cash flow (dilution-adjusted): -7216037.142857143
Buyback yield (%): 0
Retained earnings: -47963742.14285715
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -80.78719512481455
Rule of 40 score: 0
Financial ratios for SKIPPER.NS — annual report dated 2022-03-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.6989318211789529
Shares outstanding: 112904035
Market cap (USD): 78912222.80100223
Buyback yield (%): 0
Retained earnings: 73903995.78003429
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for SKIPPER.NS — annual report dated 2023-03-31
Total revenue: 238982460.41412914
Gross profit: 67586114.49451889
Operating income: 21933617.539585873
Net income: 4332034.1047503045
Capital expenditures: 10121680.876979295
Operating cash flow: 34615225.33495737
Depreciation & amortization: 5697929.354445798
Net tangible assets: 93323873.32521316
Owner earnings: -91717.41778319329
Return on net tangible assets (%): -0.09827862315956205
Capex to operating income (%): 46.14688324309316
Buffett classification: The Good
Stock price: 1.1437271619975642
P/E ratio: 29.808493748242707
Shares outstanding: 112904035
Book value: 93472959.80511573
P/B ratio: 1.38148414041722
Market cap (USD): 129131411.52862366
Debt to equity: 0.6435947788218338
Current ratio: 1.3168292546056526
Quick ratio: 0.4902818331737322
Effective tax rate (%): 28.77398165578564
Interest coverage ratio: 2.1604160668010364
COGS to revenue (%): 71.7192155535599
SG&A to revenue (%): 5.040095899892255
Free cash flow (dilution-adjusted): 24270889.15956151
Buyback yield (%): 0
Retained earnings: 72485505.48112059
Inventory turnover: 1.5409137747330541
Receivables turnover: 5.446768936933335
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 16.109725953499858
FCF margin (%): 10.155929065883267
Rule of 40 score: 10.155929065883267